AMGEN EUROPE B.V.
ItalyAll drugs from this manufacturer
-
AMGEVITA is indicated for the treatment of several inflammatory diseases, including rheumatoid arthritis, psoriatic arthritis, plaque psoriasis, Crohn's disease, ulcerative colitis, hidradenitis suppurativa, non-infectious uveitis, ankylosing spondylitis, and other forms of arthritis.
Dosage form: solution for injection
Active substance Dosage adalimumab - ATC: L04AB04
-
Aranesp is an anti-anemic medication used to treat anemia. It is prescribed to treat symptomatic anemia associated with chronic renal failure in adults and children, or for adult patients with non-bone marrow cancers receiving chemotherapy.
Dosage form: solution for injection in pre-filled syringe
Active substance Dosage darbepoetin alfa - ATC: B03XA02
-
It is used for the treatment of adults, children, and young adults with acute lymphoblastic leukemia. It is used when the disease recurs (relapse), when it does not respond to previous treatments, or when small amounts of cancer cells are still present (minimal residual disease). It can also be used during consolidation therapy.
Dosage form: powder and concentrate for solution for infusion
Active substance Dosage blinatumomab - ATC: L01FX07
-
This medicine stimulates the bone marrow to produce a greater number of white blood cells. It is used to prevent infections after chemotherapy or a bone marrow transplant, to increase stem cells before high-dose chemotherapy, to treat severe chronic neutropenia, or to reduce the risk of infection in patients with advanced HIV.
Dosage form: solution
Active substance Dosage filgrastim - ATC: L03AA02
-
It is used for the treatment of adult patients with a type of skin cancer called melanoma, in which the disease has spread to the skin or lymph nodes and cannot be surgically removed.
Dosage form: solution for injection
Active substance Dosage talimogene laherparepvec - ATC: L01XX51
-
It is prescribed for the treatment of breast cancer (early stage or metastatic) and gastric cancer, but only in cases where the tumor cells show high levels of a protein called HER2.
Dosage form: powder for concentrate for infusion solution
Active substance Dosage trastuzumab - ATC: L01FD01
-
It is used to treat adults with multiple myeloma, a type of cancer that affects plasma cells, in patients who have already received at least one previous treatment for this disease.
Dosage form: solution for infusion, powder for preparation
Active substance Dosage carfilzomib - ATC: L01XG02
-
It is used to treat adults with a type of advanced lung cancer (non-small cell lung cancer) that has spread to other parts of the body, provided that the cancer cells have a specific genetic mutation called KRAS G12C.
Dosage form: tablets, film-coated
Active substance Dosage sotorasib - ATC: L01XX73
-
It is used to reduce the duration of neutropenia (low white blood cell count) and the risk of febrile neutropenia caused by chemotherapy. It works by stimulating the bone marrow to produce more white blood cells to help the body fight infections.
Dosage form: solution for injection
Active substance Dosage pegfilgrastim - ATC: L03AA13
-
It is used to treat low platelet counts in the blood in adult and pediatric patients (from 1 year of age) suffering from immune thrombocytopenia (ITP), in cases where other treatments such as corticosteroids or immunoglobulins have not been effective.
Dosage form: powder for solution for injection
Active substance Dosage romiplostim - ATC: B02BX04
-
Otezla is used for the treatment of adults with active psoriatic arthritis, chronic moderate-to-severe plaque psoriasis, and Behçet's disease (for mouth ulcers). It is also indicated for children and adolescents aged 6 years and older weighing at least 20 kg for the treatment of moderate-to-severe plaque psoriasis.
Dosage form: tablets, film-coated
Active substance Dosage apremilast - ATC: L04AA32
-
It is used to treat secondary hyperparathyroidism in patients with severe kidney disease who require hemodialysis. It helps control calcium and phosphate levels in the body by reducing parathyroid hormone (PTH).
Dosage form: solution for injection
Active substance Dosage etelcalcetide - ATC: H05BX04
-
It is used to treat osteoporosis in postmenopausal women and in men at increased risk of fractures. It is also indicated for bone loss in men due to reduced testosterone levels (caused by surgery or therapy for prostate cancer) and for bone loss resulting from long-term glucocorticoid use in patients at risk of fracture.
Dosage form: solution for injection
Active substance Dosage denosumab - ATC: M05BX04
-
Repatha is used to lower 'bad' cholesterol levels in the blood in adults and children (from 10 years of age and older) with high levels due to various hereditary conditions, or in adults with atherosclerotic cardiovascular disease. It is used in addition to a specific diet.
Dosage form: solution for injection
Active substance Dosage evolocumab - ATC: C10AX13
-
It is used in adults to treat moderate to severe thyroid eye disease (TED). This autoimmune disease causes inflammation and swelling around the eyes, which can cause them to bulge forward, cause double vision, or damage vision.
Dosage form: powder for concentrate for infusion solution
Active substance Dosage teprotumumab - ATC: L04AG13
-
It is used to treat three rare diseases in adults: Neuromyelitis Optica Spectrum Disorder (NMOSD), IgG4-related disease (IgG4-RD), and generalized Myasthenia Gravis (gMG).
Dosage form: solution for infusion, concentrate
Active substance Dosage inebilizumab - ATC: L04AG10
-
Vectibix is used for the treatment of metastatic colorectal cancer (bowel cancer) in adult patients presenting a specific type of tumor called 'RAS wild-type tumor'.
Dosage form: solution for infusion, concentrate
Active substance Dosage panitumumab - ATC: L01FE02
-
It is used to reduce bone destruction caused by bone metastases (spread of cancer to the bones) or to treat giant cell bone tumor in adults and adolescents whose bones have stopped growing.
Dosage form: solution for injection
Active substance Dosage denosumab - ATC: M05BX04